The New Antioxidant Playbook: Inflammation, Mitochondria and Cellular Health

by Brianna Diorio PhD | June 1, 2026

As research around oxidative stress, inflammation and mitochondrial biology evolves, manufacturers are moving beyond basic antioxidant claims toward multi-pathway formulations that support cellular health, metabolic balance and long-term health outcomes.

Beyond Free Radicals: Why Cellular Health Is Bigger Than Antioxidants

For years, the antioxidant category was built on a simple story: fight free radicals and protect the body from damage. The problem is that the story is no longer enough.

Vitamin C, vitamin E and polyphenols became the foundation of this approach, often positioned with broad claims around anti-aging and cellular protection. And while those benefits still matter, the science behind oxidative stress and inflammation has evolved.

Today, antioxidants are no longer viewed as standalone solutions. They are part of a much larger biological conversation and network that influences inflammation, mitochondrial function, metabolic signaling, as well as long-term cellular resilience.1,2

As a result, the category and the conversation are shifting. Antioxidants are no longer the headline … cellular health is.

Antioxidants Are Not All the Same

One of the biggest misconceptions that still shows up in formulation strategy is the assumption that antioxidant activity is interchangeable.

Violetta Insolia, PhD, business development manager at BIONAP, Messina, Italy, said the term itself has been diluted over time. “For many years, the term antioxidant was closely associated with anti-aging. However, the antioxidant needs to be substantiated by studies proving how that activity is relevant,” she explained.

In other words, having antioxidant capacity is not enough. What matters is what that activity actually does in the body.

This is where many formulations fall short. They rely on generalized antioxidant claims without connecting them to a clear biological outcome.

James Roza, chief scientific officer at Layn Natural Ingredients, Guilin, China, said a similar issue exists when it comes to inflammation. “Inflammation is often treated as a general term without distinguishing between chronic and acute forms,” Roza said.

That distinction matters. Acute inflammation is a short-term response. Chronic inflammation is a long-term process that drives cellular damage, metabolic dysfunction and aging.2

Inflammaging Is Driving the Category Forward

Chronic low-grade inflammation has become one of the most important drivers of innovation in this space. Now commonly referred to as “inflammaging,” this process is closely tied to cellular decline and long-term health outcomes.1,2

Keely Johnson, vice president of sales and marketing at Arjuna Natural, Irving, TX, said the scale of the issue is often underestimated. “It is estimated that 35 percent of Americans are affected by chronic inflammation. It is often viewed as a silent process that damages cells and impacts longevity,” Johnson said.

This growing awareness is changing consumer expectations. Instead of broad antioxidant support, there is increasing demand for targeted solutions that address underlying drivers of cellular dysfunction.

The Shift Toward Cellular Health Systems

One of the biggest changes happening right now is the move away from single ingredients toward multi-target systems. Instead of asking what one ingredient does, formulators are asking how multiple biological pathways interact.

Ashish Suthar, PhD, managing director at BlueHelix Health, India, described this as a shift toward more biologically accurate formulations. “The biggest opportunity lies in integrated systems that reflect how cellular biology actually works,” Suthar said.

A clear example of this is NAD+ metabolism. Traditional approaches focused on increasing NAD+ levels through precursors like NR or NMN. Newer strategies are addressing both production and degradation. “Boosting NAD without preserving it is an incomplete strategy,” Suthar explained.

This reflects a broader trend toward systems-based thinking in formulation design.

Mitochondrial Health Is Back at the Center

Mitochondrial function has become one of the most important focal points in cellular health. Mitochondria regulate energy production, oxidative balance and cellular signaling. When function declines, oxidative stress increases, contributing to aging and disease.5

Roza pointed to several emerging ingredients targeting this pathway. “NMN, spermidine and urolithin A support mitochondrial function, inhibit cell senescence and protect DNA,” he said.

These ingredients go beyond traditional antioxidant activity by targeting the root mechanisms of cellular aging. At the same time, delivery technology is becoming a key differentiator.

Sebastian Balcombe, founder and chief executive officer of Specnova, Oslo, Norway, emphasized the role of bioavailability. “CoQ10 is well established as having poor bioavailability. Improving absorption should translate to greater efficacy,” he explained.

Moving Upstream: Metabolic Signaling and Regulation

Another shift is happening in how antioxidant ingredients are positioned.

Instead of reacting to oxidative stress, newer compounds are influencing upstream metabolic processes that shape those responses.

Michael Yuen, business development manager at Puredia in Montreal, Canada, explained this through omega-7. “Omega-7 is understood as a lipokine involved in metabolic signaling between tissues,” he said.

This means it may influence the biological environment that drives inflammation rather than simply responding to it. Research on sea buckthorn oil supports this approach, showing improvements in inflammatory markers, lipid metabolism and antioxidant enzyme activity.3

Bioavailability Remains the Bottleneck

Despite advances in ingredient innovation, bioavailability continues to limit efficacy. Many antioxidant compounds are poorly absorbed due to solubility and molecular structure.

Roza emphasized the importance of solving this issue. “Many ingredients are poorly absorbed. Liposomes, ingredient pairing and nanotechnology can improve utilization,” he said.

Insolia added that stability plays an equally important role. “The preservation of antioxidant activity involves developing a finished product that protects the active components,” she noted.

Clean Label and Sustainability Are Shaping Innovation

Consumer demand is also driving change. There is growing interest in plant-based, whole-food and clean-label ingredients.

Insolia noted that this shift is influencing sourcing strategies. “There has been a clear shift toward clean-label, whole-food sourced antioxidants driven by consumer demand for transparency,” she said.

Upcycled ingredients are also gaining traction, offering both sustainability benefits and brand differentiation.

Formulation Strategy Is the Differentiator

The gap between marketable and meaningful ingredients is becoming more apparent.

Johnson emphasized that clinical validation is critical. “Only a few ingredients have years of data supporting their mechanism of action and cellular activity,” she said. This reflects a broader shift toward evidence-based formulation strategies.

Human clinical data, validated mechanisms and relevant endpoints are becoming essential for differentiation.

Where the Category Is Going Next

The antioxidant category is evolving into a cellular health category. That means integrating oxidative stress, inflammation, mitochondrial function and metabolic signaling into cohesive formulations.

Suthar summarized this direction clearly. “NAD+ biology is the hub. The brands that build around that network are going to win,” he said.

This shift does not replace antioxidants. It repositions them within a larger biological system.

Final Thoughts

The category is moving from simple to complex. From isolated ingredients to interconnected systems. From marketing claims to measurable outcomes. Antioxidants still matter. But they are no longer the full story… cellular health is. NIE

*Side-bar Start

Beyond ORAC: What Actually Defines an Effective Antioxidant Today

For years, antioxidant positioning was built on simplified metrics like ORAC scores and broad claims around “fighting free radicals.”

Today, that framework is no longer sufficient. Industry experts are increasingly aligned on a key point: antioxidant activity without biological context is meaningless.

Leslie Gallo and Melanie Bush of Artemis International (Fort Wayne, IN) emphasize that one of the biggest issues in the category is the misuse of generalized claims. Terms like “antioxidant” and “anti-inflammatory” are often treated as interchangeable, despite representing distinct biological mechanisms. More importantly, reliance on legacy metrics like ORAC fails to reflect whether a compound has demonstrated meaningful effects in human systems.

Instead, the focus is shifting toward ingredient-specific validation, where efficacy is tied to standardized extracts, clinically relevant doses, and human trial data … not category-level assumptions.

Annie Eng, CEO of Florida-based HP Ingredients, expands on this by highlighting the need for greater mechanistic specificity. Antioxidants are not a single function, they interact with multiple reactive species and biological pathways.

For example, different radicals drive different types of cellular damage, from lipid membrane degradation to DNA disruption and mitochondrial stress. Eng also points to the direct link between oxidative stress and inflammation, noting that oxidative stress activates transcription factors such as NF-κB, AP-1, HIF-1α, and Nrf2, which regulate inflammatory signaling and cellular defense systems.

This reinforces a critical shift in how antioxidants should be evaluated: not just by their ability to neutralize free radicals, but by how they influence cellular pathways, signaling networks and downstream biological outcomes.

Emerging research is also placing greater emphasis on pathways like Nrf2-KEAP1-ARE, which regulate endogenous antioxidant enzyme production, detoxification processes and mitochondrial resilience. Ingredients that activate these pathways may offer more meaningful, system-wide benefits than compounds positioned solely as direct radical scavengers.

At the same time, the industry is moving toward systems-based formulation strategies, where oxidative stress, inflammation, mitochondrial function and metabolic signaling are addressed together rather than in isolation.

In practical terms, this means the definition of an “effective antioxidant” is evolving: → From high ORAC scores → To clinically validated, pathway-specific activity→ To measurable outcomes in human biology.

The takeaway is clear: The future of the category is not about how much antioxidant activity an ingredient shows in a lab. It is about whether it delivers real, measurable impact within complex biological systems.

*Side-bar end

References:

1 López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023). Hallmarks of aging: An expanding universe. Cell, 186(2), 243–278.

2 Sharma, P., & Jo, A. (2024). Systemic inflammation among adults with diagnosed and undiagnosed cardiometabolic conditions. Frontiers in Medicine, 10, 1327205.

3 Yang, B., Kallio, H., & Peippo, P. (2020). Effects of sea buckthorn (Hippophaë rhamnoides) on lipid metabolism and inflammation: A systematic review. Journal of Functional Foods, 64, 103668.

4 Del Rio, D., Rodriguez-Mateos, A., Spencer, J. P. E., Tognolini, M., Borges, G., & Crozier, A. (2023). Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects. Antioxidants & Redox Signaling, 38(5–6), 316–349.

5 Picca, A., Calvani, R., Coelho-Júnior, H. J., Marini, F., Cesari, M., & Landi, F. (2022). Mitochondrial dysfunction, oxidative stress, and aging: A comprehensive review. International Journal of Molecular Sciences, 23(3), 1248.